274,452 Shares in Akebia Therapeutics, Inc. (NASDAQ:AKBA) Bought by Balyasny Asset Management L.P.
Balyasny Asset Management L.P. bought a new position in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 274,452 shares of the biopharmaceutical company’s stock, valued at approximately $521,000. Other hedge […]
Balyasny Asset Management L.P. bought a new position in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 274,452 shares of the biopharmaceutical company’s stock, valued at approximately $521,000. Other hedge […]
